Truvestments Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$94.2K Buy
319
+2
+0.6% +$594 0.02% 391
2025
Q4
$86.7K Buy
317
+176
+125% +$47.8K 0.02% 362
2025
Q3
$38.1K Buy
141
+21
+18% +$5.71K 0.01% 480
2025
Q2
$33.2K Hold
120
0.01% 468
2025
Q1
$31.8K Buy
120
+3
+3% +$740 0.01% 479
2024
Q4
$27.2K Hold
117
0.01% 460
2024
Q3
$25.7K Buy
+117
New +$24.2K 0.01% 461
2019
Q2
Sell
-193
Closed -$32K 721
2019
Q1
$32K Buy
+193
New +$34.1K 0.02% 336
2018
Q3
$62K Buy
+363
New +$61.1K 0.03% 345

Other funds holding CME

Truvestments Capital's CME Position: Q1 2026 in Review

Truvestments Capital increased its CME Group (CME) stake by 0.63% in Q1 2026, buying an estimated $594 and bringing the position to 319 shares worth $94.2K. The position accounts for 0.02% of the portfolio, ranked #391.

Truvestments Capital first reported a position in CME in Q3 2018 and has held it in 9 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Truvestments Capital held 319 shares of CME Group worth $94.2K as of Q1 2026.
  • Truvestments Capital bought 2 CME Group shares in Q1 2026, an estimated $594.
  • CME Group made up 0.02% of Truvestments Capital's portfolio in Q1 2026, its #391 holding.
  • Truvestments Capital first reported a position in CME Group in Q3 2018 and has held it in 9 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.